US Broker Ratings

Viemed Healthcare, Inc. (VMD) Stock Analysis: A 73.56% Potential Upside Awaits Investors

For investors with a keen eye on growth opportunities in the healthcare sector, Viemed Healthcare, Inc. (VMD) presents an intriguing proposition. With an enticing potential upside of 73.56%, as indicated..

UroGen Pharma Ltd. (URGN) Stock Analysis: Investors Eye 83% Upside Amid Biotech Innovations

UroGen Pharma Ltd. (NASDAQ: URGN) is making waves in the biotechnology sector, standing out with its promising innovations in urothelial and specialty cancers. With the current stock price at $19.23,..

XOMA Royalty Corporation (XOMA): Investor Outlook Reveals a Compelling 136% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA) presents an intriguing prospect for investors with a focus on the biotechnology sector. As a dedicated royalty aggregator, XOMA has carved out a unique niche..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating the Biotech Landscape with Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling serious diseases. Operating out of San Diego, California, this..

Varex Imaging Corporation (VREX) Investor Outlook: 21.55% Potential Upside and Robust Revenue Growth

For investors eyeing opportunities in the healthcare sector, Varex Imaging Corporation (NASDAQ: VREX) presents an intriguing proposition. With a market capitalization of $593.16 million, Varex operates in the medical devices..

Sprout Social, Inc (SPT) Stock Analysis: A Look at Its 64% Potential Upside in a Competitive Market

Sprout Social, Inc. (NYSE: SPT), with its current stock price at $9.51, presents an intriguing opportunity for investors, particularly given its potential upside of 64.04% based on the average target..

Gossamer Bio, Inc. (GOSS) Investor Outlook: Biotech Stock Poised for 246.72% Upside with Promising PAH Treatment

Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company that has captured the attention of investors with its innovative approach to treating pulmonary arterial hypertension (PAH). As a key..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Biotech Gem with 95.98% Potential Upside

Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company, has caught the attention of investors with its impressive potential upside of nearly 96%. Operating in the healthcare sector and specializing in..

Neurogene Inc. (NGNE) Stock Analysis: Unpacking a 222% Upside Potential in Biotechnology

Neurogene Inc. (NASDAQ: NGNE), a promising player in the biotechnology sector, is catching the attention of investors with its substantial upside potential of 222.23%. Specializing in genetic medicines for rare..

Cartesian Therapeutics, Inc. (RNAC): Stock Analysis Reveals a Staggering 365% Potential Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing the attention of investors in the biotechnology sector, driven by its innovative approach to mRNA cell therapies for autoimmune diseases. With a current..

Marti Technologies, Inc. (MRT): An Investor Outlook on a High-Growth, High-Upside Turkish Tech Innovator

Marti Technologies, Inc. (NASDAQ: MRT), a burgeoning player in Turkey’s urban mobility landscape, is capturing investor interest with its impressive revenue growth and substantial potential upside. As a tech-driven company..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring the 161.64% Potential Upside in the Medical Devices Sector

Senseonics Holdings, Inc. (SENS) stands at a captivating juncture in the healthcare sector, particularly within the medical devices industry. This Germantown, Maryland-based company is making significant strides with its innovative..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Potential 110% Upside in the EdTech Arena

Investors with an eye on the educational technology sector should take note of Nerdy Inc. (NRDY), a company that has carved out a niche in live online learning. With its..

Aurora Cannabis Inc. (ACB): Investor Outlook with a 48.89% Potential Upside

Aurora Cannabis Inc. (NYSE: ACB), a prominent player in the healthcare sector specializing in the production and distribution of cannabis products, presents a compelling opportunity for investors intrigued by the..

Mereo BioPharma Group plc (MREO): Exploring a Potential 552.95% Upside in Biotech’s Tumultuous Terrain

For investors with a keen eye on the biotechnology sector, Mereo BioPharma Group plc (NASDAQ: MREO) is a name that might warrant your attention. With a market capitalization of $84.34..

SoundHound AI, Inc. (SOUN) Stock Analysis: Navigating a 53.6% Potential Upside Amidst Rising AI Demand

SoundHound AI, Inc. (NASDAQ: SOUN) stands at the forefront of the burgeoning voice AI industry, presenting a fascinating opportunity for investors keen on capitalizing on the rapid growth of artificial..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: Exploring a 71.82% Potential Upside with Innovative Biotech Solutions

Investors seeking opportunities in the biotechnology sector may find Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) an intriguing prospect. With a market capitalization hovering at approximately $468.64 million, this U.S.-based biopharmaceutical firm..

Pacific Biosciences of California (PACB) Stock Analysis: Navigating Challenges with Strategic Innovation

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a notable player in the healthcare sector, is making waves with its cutting-edge sequencing technologies. Based in Menlo Park, California, the company has..

Porch Group, Inc. (PRCH) Stock Analysis: Exploring a 118.94% Potential Upside

Porch Group, Inc. (NASDAQ: PRCH) is capturing the attention of investors with its innovative approach to the technology sector, particularly within the software application industry. With a market capitalization of..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a Potential 514% Upside and Innovative Biotech Prospects

aTyr Pharma, Inc. (NASDAQ: ATYR) is making waves in the biotech sector with its groundbreaking approach to treating fibrosis and inflammatory diseases. Although the company is currently trading at a..

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds